Salute e Benessere

Label-free Detection Market to Accelerate Growth from USD 2.64 Billion to USD…

This growth is mainly driven by the pharmaceutical and biotechnology industries' increasing reliance on advanced detection technologies for drug discovery, vaccine development, and biological research applications that demand high precision, real-time monitoring capabilities, and cost-effective screening solutions. This growth is mainly driven by the pharmaceutical and biotechnology industries' increasing reliance on advanced detection technologies for drug discovery, vaccine development, and...
PR Newswire
24/06/2025

Derma Fillers Market worth $7.32 billion by 2030 with 12.1% CAGR |…

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=71526267 Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=71526267 Browse in-depth TOC on "Derma Fillers Market" 400 - Tables280 - Figures320- Pages By Based on Brand,Allergan (AbbVie Inc.)'s Juvéderm brand has a complete array of hyaluronic acid (HA) dermal fillers to treat many issues, like wrinkle treatment, lip augmentation, and facial contouring...
PR Newswire
24/06/2025

New AI Rollouts Signal Shift From Hype to Healthcare Reality

According to private equity investors, this year could be even bigger than 2024 for health technology companies. Recent private raises include $101 million for Tennr, $45 million for Ellipsis Health and $28 million for Autonomize AI. In the public markets, there are several opportunities that involve actual rollouts of AI healthcare tech in practice. According to private equity investors, this yearcould be even bigger than 2024 for health technology companies. Recent private raises include ...
PR Newswire
24/06/2025

Nitinotes Announces FDA IDE Approval to Initiate Pivotal U.S. Trial of the…

This prospective, multicenter, randomized controlled trial will evaluate the safety and efficacy of the EndoZip System for the treatment of obesity. Up to 184 patients will be enrolled across as many as 10 U.S. clinical sites, with additional international sites included in accordance with FDA guidelines. As a comparative study against an already FDA-approved device, all participants will receive an active treatment, a design element expected to potentially accelerate enrollment. Patient…
PR Newswire
24/06/2025

Trusted Oncology Guidelines Get a Digital Makeover: National Comprehensive…

The new NCCN Guidelines Navigator™ presents the evidence-based, expert consensus-driven recommendations from the NCCN Guidelines in a virtual platform that allows users to search and navigate more easily. Access to the NCCN Guidelines Navigator™ is available with a free NCCN account for non-commercial use. Features of the NCCN Guidelines Navigator™ include: The newNCCN Guidelines Navigator ™ presents the evidence-based, expert consensus-driven recommendations from the NCCN Guidelines in a...
PR Newswire
24/06/2025

Vivoryon Therapeutics N.V. Reports Outcome of 2025 Annual General Meeting

Vivoryon Therapeutics N.V. Reports Outcome of 2025 Annual General MeetingHalle (Saale) / Munich, Germany, June 24 , 2025- Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) ( Vivoryon ), a clinical stage company developing small molecule medicines for inflammatory and fibrotic disorders, with a primary focus on diabetic kidney disease, held its Annual General Meeting (AGM) today at 1:00 p.m. (CEST). The shareholders approved all items on the agenda of the meeting,...
Nasdaq GlobeNewswire
24/06/2025

The Declutter Hub reveals the 10 biggest mistakes Americans make when…

Their book [https://www.bloomsbury.com/us/reset-your-home-9781399416399], published by Bloomsbury and available nationwide from today 'June 24', turns traditional tidying on its head. The core message: decluttering starts not with stuff, but with self-awareness. Their book [ https://www.bloomsbury.com/us/reset-your-home-9781399416399 ], published by Bloomsbury and available nationwide from today ' June 24 ', turns traditional tidying on its head. The core message: decluttering starts not with...
PR Newswire
24/06/2025

/C O R R E C T I O N -- FLUUS/

LONDON, June 24, 2025 /PRNewswire/ -- We've all been there - feeling uncomfortable about how we navigate basic personal hygiene - but despite the advice against doing so - flushing pads is happening (an estimated 1.5M daily go down the toilet) - causing blocked pipes and microplastics to enter waterways. LONDON , June 24, 2025 /PRNewswire/ -- We've all been there - feeling uncomfortable about how we navigate basic personal hygiene - but despite the advice against doing so - flushing pads...
PR Newswire
24/06/2025

RECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO…

RECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO COMMERCIALIZE VAZKEPA ®IN EUROPEVazkepa® supported by strong clinical data package and expected to contributeto Specialty & Primary Care growth in coming yearsMilan, 24 June 2025– Recordati today announced a licensing and supply agreement with Amarin to commercialize the marketed cardiovascular medicine, Vazkepa ®(icosapent ethyl) across 59 countries, focused in Europe. Vazkepa ®is...
Nasdaq GlobeNewswire
24/06/2025

Leerink Partners Launches London Office, Marking International Expansion

Eric Stewart has joined the firm as a Senior Managing Director to build the European Healthcare effort, in close collaboration with the broader investment banking team. He was most recently a Managing Director at Lazard, where he spent over a decade. Prior to joining Lazard in 2014, he was part of the Healthcare Investment Banking team at Houlihan Lokey and began his career at Stryker. Eric Stewarthas joined the firm as a Senior Managing Director to build the European Healthcare effort, in...
PR Newswire
24/06/2025

Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant…

Collaboration enables testing of nitrosamine impurities, allowing sponsors to demonstrate acceptable use of rifampin in drug-drug interaction studies Fortrea(Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced a strategic collaboration with Emery Pharma, a leading analytical and bioanalytical CRO providing testing services under current Good Manufacturing Practice (cGMP) and Good Laboratory Practice (GLP), to provide rapid lot-by-lot,...
Nasdaq GlobeNewswire
24/06/2025

Moon Surgical Expands Leadership Team to Accelerate Commercial Growth Across…

Joining the leadership team are: Joining the leadership team are: Jonathan Conta, Chief Marketing Officer – brings over 16 years of experience at Intuitive Surgical, where he led marketing and product functions as well as commercial initiatives across both multiport and single-port platforms. Jeff Semone, Chief Quality and Regulatory Officer – previously led global quality and regulatory teams at Siemens Healthineers and Varian Medical Systems. Jeff Driggs, Vice President of U.S...
PR Newswire
24/06/2025

Tilray Medical Receives Italy’s First Authorization from the Ministry of Health…

Beginning this month, the following Tilray Medical products are approved for therapeutic use in Italy and available for distribution through pharmacies across Italy:Tilray THC 25%Tilray THC 18%Tilray THC 9% / CBD 9% Denise Faltischek, Chief Strategy Officer and Head of International at Tilray Brands, stated, “This milestone underscores the vital role of medical cannabis as a therapeutic medicine for patients in need, supporting their health and well-being. We are proud to...
Nasdaq GlobeNewswire
24/06/2025

Amarin Announces Exclusive License and Supply Agreement with Recordati to…

-- Company to Streamline Global Operations, Resulting in Approximately $70 Million of Cost Savings Over Next 12 Months and Accelerated Path to Positive Cash Flow ---- Conference Call Today at 8:00 a.m. EDT with Investor Materials Available at AdvancingAmarin.com -- DUBLIN, Ireland and BRIDGEWATER, N.J., June24, 2025(GLOBE NEWSWIRE) -- Amarin Corporation (NASDAQ: AMRN) today announced that the Company has entered into an exclusive long-term license and supply agreement (the...
Nasdaq GlobeNewswire
24/06/2025

Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity…

Commenting on this significant opportunity, Dr. Joseph Sinkule, the CEO of KLTO, noted that "animal studies using the Klotho gene in degenerative neurological conditions produced extremely interesting results. KLTO and ORCLS scientists believe the maintenance of optimum blood levels of the Klotho protein in later life correlates with longevity, whereas lower blood levels are associated with premature aging and a propensity to develop certain neurological disorders. While results in animal…
PR Newswire
24/06/2025

Brainomix and 3DR Labs Partner to Advance Stroke Care in the US Through…

3DR Labs specializes in high-quality 3D and advanced post-processing services for medical imaging, as well as clinical AI workflow solutions. With a team of over 250 certified and registered radiologic technologists, 3DR delivers complex image reconstructions quickly, accurately, and cost-effectively – supporting radiologists, radiologic technologists, and clinicians in providing top-notch patient care. 3DR Labs specializes in high-quality 3D and advanced post-processing services for medical...
PR Newswire
24/06/2025

71% Have Faced No Way To Dispose of Period Pads in Public Bathrooms, Study…

Traditional pads take up to 500 years to biodegrade due to the plastic, glue, and absorbent polymers they contain, but 86% of people want flushable period products that solve the problem. Traditional pads take up to 500 years to biodegrade due to the plastic, glue, and absorbent polymers they contain, but 86% of people want flushable period products that solve the problem. Aside from the flushing issue - 68% didn't realise period products often contain chemicals like PFAS...
PR Newswire
24/06/2025

Breye Therapeutics announces successful completion of its Phase 1b trial with…

Danegaptide is a first-in-class oral small molecule with a novel mode of action, that stabilizes the vasculature and protects from cell-cell uncoupling, retinal capillary breakdown and vascular leakage caused by hyperglycemia. Danegaptide is a first-in-class oral small molecule with a novel mode of action, that stabilizes the vasculature and protects from cell-cell uncoupling, retinal capillary breakdown and vascular leakage caused by hyperglycemia. The orally administered treatment was well...
PR Newswire
24/06/2025

Lundbeck receives orphan drug designation in the US and EU for Lu AG13909 for…

Lu AG13909 is advancing to mid-stage clinical development, as a new therapeutic approach for conditions marked by elevated ACTH levels, such as CAH. Lundbeck is currently expanding an ongoing Phase I/II clinical open-label trial, evaluating the efficacy and safety of anti-ACTH antibody Lu AG13909 in adults with classic CAH. The trial will open for enrolment in North America and seven countries across Europe, with the first sites opening in late June 2025. Lu AG13909 is advancing to mid-stage...
PR Newswire
24/06/2025

Navamedic ASA - Investor presentation regarding the acquisition of the business…

For further information, please contact: For further information, please contact: Kathrine Gamborg Andreassen, CEO, Mobile: +47 951 78 880 E-mail:[email protected] Hjarrand, CFO, Mobile: +47 917 62 842 E-mail:[email protected] About Navamedic Navamedic ASA is a full-service provider of high-quality healthcare products to hospitals and pharmacies. Navamedic meets the specific medical needs of patients and consumers by leveraging its highly scalable market...
PR Newswire
24/06/2025

Implantica submits the last and final module 3 of the FDA PMA Application for…

In line with the positive feedback in the FDA PMA application process so far, the latest RefluxStop® data submitted as part of the Module 2 response, as well as in the final Module 3, is quite robust and conclusive in Implantica's opinion. We hope the newly submitted data and responses will not only continue to meet the stringent requirements for the PMA approval process but also exceed them. The continued process relies to a large extent now on FDA, which will guide Implantica in the coming…
PR Newswire
24/06/2025

Global Hygiene Expert Pittet: Hand Hygiene Saves 5 to 8 Million Lives Each Year

The interview The interview How many lives around the world does hand hygiene save every year? Do you dare to make an estimate? How many more lives could hand hygiene potentially save if it was practiced consistently in every country? PITTET: Hand hygiene saves lives – millions, in fact. Based on WHO estimates and our work, proper hand hygiene in healthcare settings can prevent up to 50% of healthcare-associated infections (HAIs). These infections are responsible for millions of...
PR Newswire
24/06/2025

Accord Healthcare receives approval for Hetronifly® (Serplulimab), from the…

Lung cancer remains the leading cause of cancer-related death globally. Small cell lung cancer (SCLC), one of the most aggressive subtypes, accounts for approximately 15% of all lung cancer cases and is associated with limited treatment options[1]. Lung cancer remains the leading cause of cancer-related death globally. Small cell lung cancer (SCLC), one of the most aggressive subtypes, accounts for approximately 15% of all lung cancer cases and is associated with limited treatment options [1]...
PR Newswire
24/06/2025

Sarcopenia Market to Register Sustainable Growth at a CAGR of 8.1% During the…

Key Takeaways from the Sarcopenia Market Report Key Takeaways from the Sarcopenia Market Report Discover more about the sarcopenia treatment market @Sarcopenia Medication Sarcopenia Market Dynamics The sarcopenia market is experiencing significant growth, driven by an aging global population, rising awareness, and the anticipated approval of innovative therapies such as Sarconeos, MYMD-1, and LPCN 1148. As these advanced treatments mature and gain regulatory approval, they...
PR Newswire
23/06/2025
Altri  Comunicati